
Sign up to save your podcasts
Or


Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.
By The Motley Fool4.7
16041,604 ratings
Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.

3,228 Listeners

1,498 Listeners

807 Listeners

938 Listeners

518 Listeners

1,173 Listeners

2,175 Listeners

825 Listeners

1,416 Listeners

1,044 Listeners

9,722 Listeners

196 Listeners

828 Listeners

82 Listeners

597 Listeners

989 Listeners

53 Listeners